{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:00:22Z","timestamp":1783447222657,"version":"3.55.0"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"name":"Wareham Research Grant"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,3,18]]},"abstract":"<jats:p>The antiretroviral treatment (ART) approach is the best-prescribed approach to date for preexposure prophylaxis (PrEP) for high-risk individuals. However, the daily combination antiretroviral (cARV) regimen has become cumbersome for healthy individuals, leading to nonadherence.<\/jats:p>","DOI":"10.1128\/aac.02320-20","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T06:33:32Z","timestamp":1612161212000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure Prophylaxis"],"prefix":"10.1128","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0047-4305","authenticated-orcid":true,"given":"Subhra","family":"Mandal","sequence":"first","affiliation":[{"name":"School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2463-3350","authenticated-orcid":true,"given":"Pavan Kumar","family":"Prathipati","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawnalyn W.","family":"Sunagawa","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-3939","authenticated-orcid":true,"given":"Christopher J.","family":"Destache","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Health Professions, Creighton University, Omaha, Nebraska, USA"},{"name":"School of Medicine, Division of Infectious Diseases, Creighton University, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwaa081"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2018.1511346"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.2217\/nnm.12.214"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001896"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-041217-013717"},{"key":"e_1_3_3_7_2","unstructured":"ViiV Healthcare\/Gilead Sciences. 2016. Safety and efficacy study of injectable cabotegravir compared to daily oral tenofovir disoproxil fumarate\/emtricitabine (TDF\/FTC) for pre-exposure prophylaxis in HIV-uninfected cisgender men and transgender women who have sex with men. NIAID\/NIH\/National Library of Medicine Bethesda MD. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02720094."},{"key":"e_1_3_3_8_2","volume-title":"Long-acting injectable drug prevents HIV among men who have sex with men and transgender women","author":"NIAID","year":"2020","unstructured":"NIAID. 2020. Long-acting injectable drug prevents HIV among men who have sex with men and transgender women. NIAID\/NIH\/National Library of Medicine, Bethesda, MD."},{"key":"e_1_3_3_9_2","volume-title":"Bictegravir","author":"DrugBank","year":"2016","unstructured":"DrugBank. 2016. Bictegravir. DrugBank. https:\/\/go.drugbank.com\/drugs\/DB11799."},{"key":"e_1_3_3_10_2","unstructured":"Gilead. 2020. Bictegravir\/emtricitabine\/tenofovir alafenamide\u2014brand name: Biktarvy. NIH\/AIDSinfo Bethesda MD. https:\/\/aidsinfo.nih.gov\/drugs\/589\/biktarvy\/0\/patient."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01474-16"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4379"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30080-3"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001744"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000940"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60616-X"},{"key":"e_1_3_3_17_2","volume-title":"Bictegravir\/emtricitabine\/tenofovir alafenamidebictegravir\/emtricitabine\/tenofovir alafenamide","author":"AIDSinfo","year":"2020","unstructured":"AIDSinfo. 2020. Bictegravir\/emtricitabine\/tenofovir alafenamidebictegravir\/emtricitabine\/tenofovir alafenamide. UNAIDS\/AIDSinfo, New York, NY. https:\/\/aidsinfo.nih.gov\/drugs\/589\/biktarvy\/0\/patient."},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000374"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e3283582d4a"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.06.005"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.12.027"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2017.08.007"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.04.007"},{"key":"e_1_3_3_24_2","volume-title":"NIH: TZM-bl cells, ARP-8129 on division of AIDS","author":"Kappes JC","year":"2019","unstructured":"Kappes JC, Wu X. 2019. NIH: TZM-bl cells, ARP-8129 on division of AIDS. HIV Reagent Program\/ATCC, Manassas, VA. https:\/\/www.hivreagentprogram.org\/Catalog\/cellBanks\/ARP-8129.aspx."},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01095-12"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01431-12"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01475-16"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001349"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.07.032"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2020.01.016"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2014.0210"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000002"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01260"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1039\/C7RA04748G"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-019-00443-1"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-014-2527-7"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12192"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.7497\/j.issn.2095-3941.2014.04.003"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1021\/mp100255c"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00589"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.22580\/2016\/iSciNote1.1AA"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEB.2012.0443"},{"key":"e_1_3_3_43_2","first-page":"624","volume-title":"Physical chemistry for the life sciences","author":"Atkins P","year":"2015","unstructured":"Atkins P, Paula J. 2015. The second law, p 624, Physical chemistry for the life sciences, 2nd ed. Oxford University Press, Oxford, United Kingdom.","edition":"2"},{"key":"e_1_3_3_44_2","first-page":"508","volume-title":"Physical chemistry for the biosciences","author":"Chang R","year":"2005","unstructured":"Chang R. 2005. Intracellular forces, p 508\u2013510. In Physical chemistry for the biosciences. University Science Books, Mill Valley, CA."},{"key":"e_1_3_3_45_2","volume-title":"Biochemistry","author":"Garrett RH","year":"2012","unstructured":"Garrett RH, Grisham CM. 2012. Role in biomolecular interactions. In Biochemistry, 5th ed. Cengage Learning, Boston, MA.","edition":"5"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2015.11.009"},{"key":"e_1_3_3_47_2","first-page":"146","article-title":"The role of drug lipophilicity in release from intra-adipose and intramuscular injection sites","volume":"3","author":"Kadir F","year":"1991","unstructured":"Kadir F, Zuidema J, Pijpers A, Vulto A, Verheijden JH. 1991. The role of drug lipophilicity in release from intra-adipose and intramuscular injection sites. Eur J Drug Metab Pharmacokinet Spec No 3:146\u2013149.","journal-title":"Eur J Drug Metab Pharmacokinet Spec No"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S106297"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/polym3031377"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.78"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/srep43047"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.2174\/1570162X15666171120110145"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2018.03.005"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008046"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy189"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2002.121829"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.086744"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.603242"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2013.s1.e5"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv528"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1063\/1.4926584"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2016.07.040"},{"key":"e_1_3_3_63_2","volume-title":"Bioanalytical method validation: guidance for industry","author":"FDA","year":"2018","unstructured":"FDA. 2018. Bioanalytical method validation: guidance for industry. U.S. FDA, Bethesda, MD. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02320-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02320-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:37:24Z","timestamp":1645486644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02320-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,18]]}},"alternative-id":["10.1128\/AAC.02320-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.02320-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"2020-11-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e02320-20"}}